Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage - PubMed (original) (raw)
. 2003 Nov 6;426(6962):87-91.
doi: 10.1038/nature02082.
Affiliations
- PMID: 14603323
- DOI: 10.1038/nature02082
Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage
Luca Busino et al. Nature. 2003.
Abstract
The Cdc25A phosphatase is essential for cell-cycle progression because of its function in dephosphorylating cyclin-dependent kinases. In response to DNA damage or stalled replication, the ATM and ATR protein kinases activate the checkpoint kinases Chk1 and Chk2, which leads to hyperphosphorylation of Cdc25A. These events stimulate the ubiquitin-mediated proteolysis of Cdc25A and contribute to delaying cell-cycle progression, thereby preventing genomic instability. Here we report that beta-TrCP is the F-box protein that targets phosphorylated Cdc25A for degradation by the Skp1/Cul1/F-box protein complex. Downregulation of beta-TrCP1 and beta-TrCP2 expression by short interfering RNAs causes an accumulation of Cdc25A in cells progressing through S phase and prevents the degradation of Cdc25A induced by ionizing radiation, indicating that beta-TrCP may function in the intra-S-phase checkpoint. Consistent with this hypothesis, suppression of beta-TrCP expression results in radioresistant DNA synthesis in response to DNA damage--a phenotype indicative of a defect in the intra-S-phase checkpoint that is associated with an inability to regulate Cdc25A properly. Our results show that beta-TrCP has a crucial role in mediating the response to DNA damage through Cdc25A degradation.
Similar articles
- SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase.
Jin J, Shirogane T, Xu L, Nalepa G, Qin J, Elledge SJ, Harper JW. Jin J, et al. Genes Dev. 2003 Dec 15;17(24):3062-74. doi: 10.1101/gad.1157503. Epub 2003 Dec 17. Genes Dev. 2003. PMID: 14681206 Free PMC article. - Differential roles for checkpoint kinases in DNA damage-dependent degradation of the Cdc25A protein phosphatase.
Jin J, Ang XL, Ye X, Livingstone M, Harper JW. Jin J, et al. J Biol Chem. 2008 Jul 11;283(28):19322-8. doi: 10.1074/jbc.M802474200. Epub 2008 May 13. J Biol Chem. 2008. PMID: 18480045 Free PMC article. - Beta-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases.
Kanemori Y, Uto K, Sagata N. Kanemori Y, et al. Proc Natl Acad Sci U S A. 2005 May 3;102(18):6279-84. doi: 10.1073/pnas.0501873102. Epub 2005 Apr 21. Proc Natl Acad Sci U S A. 2005. PMID: 15845771 Free PMC article. - Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis.
Busino L, Chiesa M, Draetta GF, Donzelli M. Busino L, et al. Oncogene. 2004 Mar 15;23(11):2050-6. doi: 10.1038/sj.onc.1207394. Oncogene. 2004. PMID: 15021892 Review. - The characteristics and roles of β-TrCP1/2 in carcinogenesis.
Bi Y, Cui D, Xiong X, Zhao Y. Bi Y, et al. FEBS J. 2021 Jun;288(11):3351-3374. doi: 10.1111/febs.15585. Epub 2020 Oct 23. FEBS J. 2021. PMID: 33021036 Review.
Cited by
- The Potential for Targeting G2/M Cell Cycle Checkpoint Kinases in Enhancing the Efficacy of Radiotherapy.
Melia E, Parsons JL. Melia E, et al. Cancers (Basel). 2024 Aug 29;16(17):3016. doi: 10.3390/cancers16173016. Cancers (Basel). 2024. PMID: 39272874 Free PMC article. Review. - Regulation of biological processes by ubiquitin ligases: a focus on the Pagano Lab's contribution.
Kaldis P, Porter LA. Kaldis P, et al. Front Cell Dev Biol. 2024 Aug 15;12:1458895. doi: 10.3389/fcell.2024.1458895. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39211389 Free PMC article. - In Fanconi anemia, impaired accumulation of bone marrow neutrophils during emergency granulopoiesis induces hematopoietic stem cell stress.
Hu L, Huang W, Liu B, Eklund EA. Hu L, et al. J Biol Chem. 2024 Aug;300(8):107548. doi: 10.1016/j.jbc.2024.107548. Epub 2024 Jul 9. J Biol Chem. 2024. PMID: 38992437 Free PMC article. - Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options.
Gao H, Xi Z, Dai J, Xue J, Guan X, Zhao L, Chen Z, Xing F. Gao H, et al. Mol Cancer. 2024 May 3;23(1):88. doi: 10.1186/s12943-024-02005-y. Mol Cancer. 2024. PMID: 38702734 Free PMC article. Review. - ZNF827 is a single-stranded DNA binding protein that regulates the ATR-CHK1 DNA damage response pathway.
Yang SF, Nelson CB, Wells JK, Fernando M, Lu R, Allen JAM, Malloy L, Lamm N, Murphy VJ, Mackay JP, Deans AJ, Cesare AJ, Sobinoff AP, Pickett HA. Yang SF, et al. Nat Commun. 2024 Mar 12;15(1):2210. doi: 10.1038/s41467-024-46578-0. Nat Commun. 2024. PMID: 38472229 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous